Healthcare -
Biotechnology - NASDAQ - US
$ 0.023
-0.87 %
$ 914 K
Market Cap
-0.02
P/E
VIRX - STOCK-BASED COMPENSATION
Stock-based Compensation VIRX - Viracta Therapeutics, Inc.
7.65 M
LAST VALUE
17.48%
2 YEAR CAGR
105.13%
5 YEAR CAGR
7.01%
10 YEAR CAGR